English

More about this topic

Business

Drugmaker Novo Nordisk reaches market value of $500 million

Demand for obesity drugs has pushed Novo Nordisk's share price to new highs.

Earth News

Pharma and cosmetics industries to pay for wastewater treatment

‘Polluter pays’ principle mandates key industries to take responsibility for spreading micropollutants.

Health news

€2.5 million drug now approved in Ireland, Belgium and the Netherlands

Libmeldy - a treatment for a rare disease costing €2.5 million - has become available in Ireland, Belgium and the Netherlands.

Health news

'I’m scared': UK patients struggle to access epilepsy medication

A national shortage of some epilepsy medications in the UK is putting patients' safety at risk.

ADVERTISEMENT

Health news

Scientists discover first new antibiotics in over 60 years using AI

A new class of antibiotics for drug-resistant Staphylococcus aureus (MRSA) bacteria which was discovered using more transparent deep learning models.

Health news

AI could change the game for drug development

Biotech startups are using AI to speed drug discovery, revolutionising pharmaceuticals. Iktos aims to halve pre-clinical drug discovery time.

Health news

Americans turn to alternatives amid Ozempic shortage

Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug.

Health news

Australia has apologised to thalidomide survivors. What about Europe?

The Australian government issued formal apologies to victims of thalidomide this week. In Europe, the recognition of victims has been heterogeneous.

Business

Denmark's Novo Nordisk invests €2.1 billion in France

Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug.

France

Five hundred new jobs coming in Chartres, south of Paris

On Thursday, Danish pharmaceutical giant Novo Nordisk announced a major investment in a French production site to expand the capacity and manufacturing of a blockbuster anti-obesity drug.

Healthcare

France debates amendment on biomedicine substitution in pharmacies

An amendment is being debated on whether pharmacies can substitute approved replacements for biological medicines, but patient organisations have raised concerns.

Business

AstraZeneca announces new anti-obesity drug deal and positive profit

AstraZeneca's share price climbed on Thursday after it announced a multi-billion dollar deal with Chinese biopharmaceutical company Eccogene to produce a new anti-diabetes and obesity drug.

Health news

Growing drugs shortage is leaving pharmacists and patients in the dark

Shortages of common older medicines are increasing. Experts say it’s in part because pharmaceutical companies are de-incentivised from producing them.

Business

Denmark's Novo Nordisk and South Africa's Aspen to produce insulin for African patients

Last year, the World Health Organization estimated that there are 24 million adults living with diabetes in Africa, saying the number is expected to rise to 55 million by 2045.

Economy

Denmark's economy boosted by anti-obesity treatments

Over the first six months of the year, Danish GDP rose by 1.7% year-on-year, according to national statistics, but without the contribution of the pharmaceutical industry, it would have fallen by 0.3%.

Health news

Anti-obesity drug market booming with new class of popular drugs

Designed to treat obesity, a new class of drugs is also an opportunity for investors.

Health news

Weight-loss drug Wegovy could reduce risk of heart attack or stroke

Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient.

Smart Health

Prescription for Disaster: Europe faces medicine shortages crisis

In partnership with The European Commission

In Lithuania, people have to travel across the country to get ahold of much-needed prescriptions.

Smart Health

How to prevent medicine shortages in Europe?

In partnership with The European Commission

European countries are struggling to get ahold of essential medicine supplies for its citizens. In Lithuania, the problem is no different, and many people are growing impatient.

Health news

New Alzheimer’s drug gets full approval from US regulators

The treatment received conditional approval in January, but received full approval following a review of data from a further 1,800 patient study that showed the drug slowed cognitive decline by 5 months.